ArticleSensors (Basel, Switzerland)2024
Breast Lesion Detection for Ultrasound Images Using MaskFormer.
Article in Sensors (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Variational mode directed deep learning framework for breast lesion classification using ultrasound imaging.Scientific reports · 2025Article
- Automated Segmentation of Breast Cancer Focal Lesions on Ultrasound Images.Sensors (Basel, Switzerland) · 2025Article
- Automatic Measurement of Frontomaxillary Facial Angle in Fetal Ultrasound Images Using Deep Learning.Sensors (Basel, Switzerland) · 2025Article
- Superior diagnostic performance of computed tomography over abdominal ultrasound for ovarian cancer detection.American journal of translational research · 2025Article
- The role of artificial intelligence in enhancing breast cancer screening and diagnosis: A review of current advances.BioImpacts : BI · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
This study evaluates the performance of the MaskFormer model for segmenting and classifying breast lesions using ultrasound images, addressing ultrasound's limitations. Ultrasound used for breast cancer detection faces challenges like low image contrast and difficulty in the detection of small or multiple lesions, further complicated by variability based on operator skill. Initial experiments with U-Net and other CNN-based models revealed constraints, such as early plateauing in model loss, which indicated suboptimal learning and performance. In contrast, MaskFormer demonstrated continuous improvement, achieving higher precision in breast lesion segmentation and significantly reducing both false positives and false negatives. Comparative analysis showed MaskFormer's superior performance, with the highest precision and recall rates for malignant lesions and an overall mean average precision (mAP) of 0.943. The model's ability to detect a diverse range of breast lesions, including those potentially missed by the human eye, especially by less experienced practitioners, underscores its potential. These findings suggest that integrating AI models like MaskFormer could greatly enhance ultrasound performance for breast cancer detection, providing reliable, operator-independent image analysis and potentially improving patient outcomes on a global scale.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.